SEC Filing Details
Document Details
Form
Filing Date
Feb 25, 2020
Document Date
Feb 22, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.
Filer
Bowden Christopher
